Court Ruling Limits Mail-Order Access to Abortion Pill Mifepristone

A lower court has issued a ruling restricting mail-order access to the abortion pill mifepristone, requiring in-person dispensing. The drug manufacturer argues this restriction causes irreparable harm to patients seeking the medication. The Supreme Court has been asked to pause the ruling while considering the broader implications for reproductive healthcare access.